Literature DB >> 23406473

New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition.

Guzmán Alvarez1, Jennyfer Martínez, Beatriz Aguirre-López, Nallely Cabrera, Leticia Pérez-Díaz, Marietta Tuena de Gómez-Puyou, Armando Gómez-Puyou, Ruy Pérez-Montfort, Beatriz Garat, Alicia Merlino, Mercedes González, Hugo Cerecetto.   

Abstract

CONTEXT: Triosephosphate isomerase (TIM) is a ubiquitous enzyme that has been targeted for the discovery of new small molecular weight compounds used against Trypanosoma cruzi, the causative agent of Chagas disease. We have identified phenazine and 1,2,6-thiadiazine chemotypes as novel inhibitors of TIM from T. cruzi (TcTIM).
OBJECTIVE: Study the mechanism of TcTIM inhibition by a phenazine derivative and by a 1,2,6-thiadiazine derivative.
METHODS: We performed biochemical and theoretical molecular docking studies to characterize the interaction of the derivatives with wild-type and mutant TcTIM. RESULTS AND
CONCLUSION: At low micromolar concentrations, the compounds induce highly selective irreversible inactivation of parasitic TIM. The molecular docking simulations indicate that the phenazine derivative likely interferes with the association of the two monomers of the dimeric enzyme by locating at the dimer interface, while 1,2,6-thiadiazine could act as an inhibitor binding to a region surrounding Cys-118.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406473     DOI: 10.3109/14756366.2013.765415

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  8 in total

1.  Computational models for neglected diseases: gaps and opportunities.

Authors:  Elizabeth L Ponder; Joel S Freundlich; Malabika Sarker; Sean Ekins
Journal:  Pharm Res       Date:  2013-08-30       Impact factor: 4.200

2.  Difference FTIR Studies of Substrate Distribution in Triosephosphate Isomerase.

Authors:  Hua Deng; Jayson Vedad; Ruel Z B Desamero; Robert Callender
Journal:  J Phys Chem B       Date:  2017-10-20       Impact factor: 2.991

3.  Bigger data, collaborative tools and the future of predictive drug discovery.

Authors:  Sean Ekins; Alex M Clark; S Joshua Swamidass; Nadia Litterman; Antony J Williams
Journal:  J Comput Aided Mol Des       Date:  2014-06-19       Impact factor: 3.686

4.  Species-Specific Inactivation of Triosephosphate Isomerase from Trypanosoma brucei: Kinetic and Molecular Dynamics Studies.

Authors:  Alejandra Vázquez-Raygoza; Lucia Cano-González; Israel Velázquez-Martínez; Pedro Josué Trejo-Soto; Rafael Castillo; Alicia Hernández-Campos; Francisco Hernández-Luis; Jesús Oria-Hernández; Adriana Castillo-Villanueva; Claudia Avitia-Domínguez; Erick Sierra-Campos; Mónica Valdez-Solana; Alfredo Téllez-Valencia
Journal:  Molecules       Date:  2017-11-24       Impact factor: 4.411

5.  Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity.

Authors:  Florencia Ferraro; Ileana Corvo; Lucia Bergalli; Andrea Ilarraz; Mauricio Cabrera; Jorge Gil; Brian M Susuki; Conor R Caffrey; David J Timson; Xavier Robert; Christophe Guillon; Teresa Freire; Guzmán Álvarez
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

6.  The compound packaged in virions is the key to trigger host glycolysis machinery for virus life cycle in the cytoplasm.

Authors:  Siyuan Zhang; Fan Xin; Xiaobo Zhang
Journal:  iScience       Date:  2020-12-09

Review 7.  Advances in Phenazines over the Past Decade: Review of Their Pharmacological Activities, Mechanisms of Action, Biosynthetic Pathways and Synthetic Strategies.

Authors:  Junjie Yan; Weiwei Liu; Jiatong Cai; Yiming Wang; Dahong Li; Huiming Hua; Hao Cao
Journal:  Mar Drugs       Date:  2021-10-27       Impact factor: 5.118

8.  Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity.

Authors:  Luiz Saramago; Helga Gomes; Elena Aguilera; Hugo Cerecetto; Mercedes González; Mauricio Cabrera; Maria Fernanda Alzugaray; Itabajara da Silva Vaz Junior; Rodrigo Nunes da Fonseca; Beatriz Aguirre-López; Nallely Cabrera; Ruy Pérez-Montfort; Alicia Merlino; Jorge Moraes; Guzmán Álvarez
Journal:  Vet Sci       Date:  2018-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.